Leaders from Stryker, Zimmer Biomet, Smith+Nephew and more share how COVID-19 has inspired them to rethink business practices, strategies and market forecasts.
The two entities will form MW Industries Life Sciences. Toby Buck, former CEO and Chairman of Paragon Medical, will serve as President of the division upon the transaction's close in 4Q20.
Industry leaders that adopt additive manufacturing are delivering highly effective products at a reduced overall cost, and helping to improve the standard of care.
Two companies entered into the total ankle replacement market this year (In2Bones and Paragon 28), and Kinos Medical gained its first FDA 510(k) clearance with its implant.
Device companies are continually pressuring contract manufacturers to reduce costs. This case study shows how cannulated raw material can reduce launch time and improve manufacturing efficiency.
Orteq is taking steps toward FDA 510(k) clearance and hopes that their extensive body of scientific and clinical evidence from Europe will support a timely introduction to the U.S.
These changes may affect when you file for trademark protection, and present a need for device companies to implement a best-practice policy to maintain your current registered trademarks.
Most auditors pretend to “add value.” Adding value is a cliché. In this article, you will learn three auditing techniques that actually improve product development (or any process).
